In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alantos closes $20mm Series B round

Executive Summary

Alantos Pharmaceuticals Holding Inc. (formerly Therascope AG; small-molecule drugs for osteoarthritis, inflammation, and Type II diabetes) brought in $20mm with its Series B financing led by returning shareholder Oxford Bioscience Partners. Other existing backers SV Life Sciences, Earlybird, ABN AMRO, Heidelberg Innovation, and Ventech also participated in the round.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies